Market overview
The global organ preservation solution market is worth USD 454 mn in 2026 and is forecast to reach USD 935 mn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Static cold-storage solutions is the largest by type segment.
| Scope | Cold-storage and perfusion solutions used to preserve kidneys, livers, hearts, lungs and pancreas between donation and transplant, including consumable sets for machine perfusion. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 420 mn |
| Value 2026 | USD 454 mn |
| Value 2036 | USD 935 mn |
| CAGR 2026-2036 | 7.5% |
| Volume 2026 | 372 thousand units |
| Volume 2036 | 661 thousand units |
| Average price 2026 | USD 1,218 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Organ Preservation Solution market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 454 mn |
| 2027 | USD 488 mn |
| 2028 | USD 524 mn |
| 2029 | USD 564 mn |
| 2030 | USD 606 mn |
| 2031 | USD 651 mn |
| 2032 | USD 700 mn |
| 2033 | USD 753 mn |
| 2034 | USD 809 mn |
| 2035 | USD 870 mn |
| 2036 | USD 935 mn |
Organ Preservation Solution market segmentation
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Static cold-storage solutions | 48.0% | 39.0% | USD 218 mn | 5.3% |
| Machine perfusion solutions and sets | 36.0% | 48.6% | USD 163 mn | 10.8% |
| Cardioplegic and flush solutions | 16.0% | 12.4% | USD 73 mn | 4.8% |
By organ
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Kidney | 40.0% | 38.4% | USD 181 mn | 7.1% |
| Liver | 24.0% | 25.3% | USD 109 mn | 8.1% |
| Heart | 16.0% | 17.6% | USD 73 mn | 8.6% |
| Lung | 12.0% | 12.1% | USD 54 mn | 7.5% |
| Pancreas and other | 8.0% | 6.7% | USD 36 mn | 5.6% |
By solution brand type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Intracellular-type solutions | 44.0% | 38.0% | USD 200 mn | 5.9% |
| Extracellular-type solutions | 30.0% | 29.0% | USD 136 mn | 7.1% |
| Histidine-based solutions | 26.0% | 33.0% | USD 118 mn | 10.1% |
By organ-specific use
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Kidney and pancreas | 36.0% | 35.0% | USD 163 mn | 7.2% |
| Liver and intestine | 28.0% | 28.0% | USD 127 mn | 7.5% |
| Heart and lung | 36.0% | 37.0% | USD 163 mn | 7.8% |
By storage temperature
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Static cold storage | 74.0% | 64.0% | USD 336 mn | 6.0% |
| Machine-perfusion compatible | 18.0% | 26.0% | USD 82 mn | 11.5% |
| Cryopreservation-compatible | 8.0% | 10.0% | USD 36 mn | 9.9% |
Top 25 countries for organ preservation solution by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 88.5% of 2026 revenue and the 25 countries below together hold 96.6%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 191 mn | 42.0% | USD 390 mn | 7.4% |
| 2 | Germany | USD 36 mn | 8.0% | USD 71 mn | 7.0% |
| 3 | China | USD 36 mn | 8.0% | USD 93 mn | 9.9% |
| 4 | United Kingdom | USD 27 mn | 6.0% | USD 56 mn | 7.5% |
| 5 | France | USD 23 mn | 5.0% | USD 44 mn | 6.8% |
| 6 | Japan | USD 23 mn | 5.0% | USD 42 mn | 6.4% |
| 7 | Italy | USD 18 mn | 4.0% | USD 36 mn | 7.0% |
| 8 | Spain | USD 18 mn | 4.0% | USD 36 mn | 7.0% |
| 9 | Canada | USD 16 mn | 3.5% | USD 33 mn | 7.5% |
| 10 | Australia | USD 14 mn | 3.0% | USD 28 mn | 7.5% |
| 11 | Netherlands | USD 7.2 mn | 1.6% | USD 15 mn | 7.4% |
| 12 | Switzerland | USD 6.0 mn | 1.3% | USD 12 mn | 7.4% |
| 13 | Belgium | USD 4.9 mn | 1.1% | USD 10 mn | 7.4% |
| 14 | Sweden | USD 4.0 mn | 0.9% | USD 8.1 mn | 7.4% |
| 15 | Austria | USD 3.0 mn | 0.7% | USD 6.1 mn | 7.3% |
| 16 | Denmark | USD 2.5 mn | 0.6% | USD 5.1 mn | 7.5% |
| 17 | Norway | USD 1.9 mn | 0.4% | USD 4.0 mn | 7.5% |
| 18 | South Korea | USD 1.5 mn | 0.3% | USD 3.1 mn | 7.2% |
| 19 | Brazil | USD 1.2 mn | 0.3% | USD 2.5 mn | 7.5% |
| 20 | Mexico | USD 1.1 mn | 0.2% | USD 2.2 mn | 7.5% |
| 21 | India | USD 0.91 mn | 0.2% | USD 1.9 mn | 7.5% |
| 22 | Poland | USD 0.73 mn | 0.2% | USD 1.5 mn | 7.5% |
| 23 | Israel | USD 0.59 mn | 0.1% | USD 1.2 mn | 7.5% |
| 24 | Argentina | USD 0.50 mn | 0.1% | USD 1.0 mn | 7.5% |
| 25 | Singapore | USD 0.41 mn | 0.09% | USD 0.84 mn | 7.5% |
| Rest of world | USD 16 mn | 3.4% | USD 32 mn | 7.4% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Bridge to Life
- XVIVO Perfusion
- Dr. Franz Kohler Chemie
- Terumo
- TransMedics
- Getinge
Group 2: Regional and specialist players
- Paragonix Technologies
- Organ Recovery Systems
- Institut Georges Lopez
- BioLife Solutions
Group 3: Emerging and niche players
- Waters Medical Systems
- Hemarina
- Aferetica
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the organ preservation solution market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.
The market is divided by type, by organ, by solution brand type, by organ-specific use, by storage temperature. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the organ preservation solution market?
The global organ preservation solution market is estimated at USD 420 mn in 2025 and USD 454 mn in 2026.
How fast will the organ preservation solution market grow?
It is forecast to reach USD 935 mn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 481 mn.
Which country is the largest market for organ preservation solution?
United States is the largest market by revenue at USD 191 mn in 2026, 42.0% of the global total. The three largest countries together hold 58.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 9.9% a year from 2026 to 2036.
Which organ preservation solution segment is largest?
In the by type split, Static cold-storage solutions is the largest segment with 48.0% of 2026 revenue.
Who are the leading organ preservation solution companies?
Global leaders include Bridge to Life, XVIVO Perfusion, Dr. Franz Kohler Chemie, Terumo.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Tattoo Removal LaserUSD 454 mn · 7.5% CAGR
- Cosmetic Peptide ManufacturingUSD 456 mn · 8.0% CAGR
- PET Imaging WorkflowUSD 456 mn · 8.0% CAGR
- Catheter-Directed ThrombolysisUSD 452 mn · 7.5% CAGR
- Cell-Free DNA Testing TransplantUSD 462 mn · 10.0% CAGR
- Home Infusion Smart Pump AccessoriesUSD 445 mn · 6.5% CAGR
- AI enhanced Mammography ScreeningUSD 434 mn · 19.0% CAGR
- Waterless Bathing SolutionUSD 475 mn · 5.3% CAGR
← Organ Preservation & Perfusion Products Orthopedic Devices →